Amryt Pharma plc American Depositary Shares
AMYT
AMYT was delisted on the 11th of April, 2023.
15 hedge funds and large institutions have $186M invested in Amryt Pharma plc American Depositary Shares in 2020 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 2 closing their positions.
300% more funds holding in top 10
Funds holding in top 10: 1 → 4 (+3)
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
185% more capital invested
Capital invested by funds: $65.3M → $186M (+$121M)
25% more funds holding
Funds holding: 12 → 15 (+3)
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$26M |
| 2 |
ACM
Aquilo Capital Management
San Francisco,
California
|
+$10.4M |
| 3 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$8.5M |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
+$2.61M |
| 5 |
HCM
Highbridge Capital Management
New York
|
+$1.96M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$5.8M |
| 2 |
EIG
EdgePoint Investment Group
Toronto,
Ontario, Canada
|
-$3.94M |
| 3 |
AC
Armistice Capital
New York
|
-$1.38M |
| 4 |
WA
Whitebox Advisors
Minneapolis,
Minnesota
|
-$81.9K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$7K |
AMYT Hedge Fund Activity: Q4 2020 in Review
15 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Amryt Pharma plc American Depositary Shares (AMYT) for Q4 2020, worth a combined $186M — up 185% from $65.3M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new AMYT positions and 2 closed out — a net gain of 4 holders — while 2 added to existing stakes and 4 trimmed.
The largest buyer was UBS O'Connor, opening a new position worth an estimated $26M. The largest seller was Ameriprise, cutting an estimated $5.8M.
- 15 institutional investors held Amryt Pharma plc American Depositary Shares (AMYT) as of Q4 2020, up from 12 in Q3 2020.
- Funds reported $186M of Amryt Pharma plc American Depositary Shares stock for Q4 2020, up 185% quarter-over-quarter.
- 6 funds opened new Amryt Pharma plc American Depositary Shares positions in Q4 2020 and 2 closed out, a net change of +4 holders.
- The largest Amryt Pharma plc American Depositary Shares buyer in Q4 2020 was UBS O'Connor, an estimated $26M added.
- The largest Amryt Pharma plc American Depositary Shares seller in Q4 2020 was Ameriprise, an estimated $5.8M sold.
Based on aggregated 13F filings for Q4 2020.